Behavioral and pharmacological treatment of obsessive-compulsive disorders.
Single-case experimental designs were used to evaluate behavioral and pharmacological treatments in obsessive-compulsive disorders. Four patients were treated in variants of ABAB withdrawal design using behavioral and self-report data as dependent variables. Three of the four patients responded to behavioral or pharmacological treatment, whereas one patient responded to neither intervention.
D000293:Adolescent; D000328:Adult; D001521:Behavior Therapy / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D004316:Doxepin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D007171:Implosive Therapy; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000523:psychology / Q000628:therapy*
D004316:Doxepin; D007099:Imipramine